FDA OKs product for aiding in cataract surgery:
This article was originally published in Clinica
Executive Summary
The US FDA has approved for the first time a product for staining the anterior lens capsule during cataract surgery. Vision Blue (trypan blue ophthalmic solution), made by Dutch firm DORC International, enhances the ability of ophthalmologists to remove white cataracts - very advanced mature cataracts - by allowing the capsule to be observed as it is cut and removed. Clean cuts in the capsule are known to reduce some of the risks associated with the surgical removal of a cataract, said the FDA. The agency noted that of the 1.4 million people that undergo cataract surgery each year in the US, mature white cataracts account for only a small portion. Vision Blue is currently marketed in 30 countries.
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.